FERROSAN MEDICAL DEVICES A/S financials
FERROSAN MEDICAL DEVICES A/S
984500BF93C2D0DCWE27 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | DKK 1.08B | DKK 996.7M |
| Cost of sales | DKK 279.6M | DKK 251.1M |
| Gross profit | DKK 799.1M | DKK 815.1M |
| Other income | DKK 0 | DKK 69.5M |
| Employee benefits expense | DKK 274.7M | DKK 237.0M |
| Operating profit (EBIT) | DKK 217.6M | DKK 290.6M |
| Finance costs | DKK 156.6M | DKK 143.1M |
| Profit before tax | DKK 64.2M | DKK 156.9M |
| Income tax expense | DKK 31.1M | DKK 61.6M |
| Profit for the year | DKK 33.1M | DKK 95.3M |
| Total comprehensive income | DKK 39.2M | DKK 94.1M |
| Cash flow statement | ||
| Net cash from operating activities | DKK 86.5M | DKK 199.0M |
| Net cash from investing activities | -DKK 193.1M | -DKK 268.3M |
| Purchase of PP&E (capex) | DKK 128.1M | DKK 196.6M |
| Purchase of intangibles | DKK 70.3M | DKK 71.7M |
| Net cash from financing activities | DKK 168.5M | DKK 69.1M |
| Dividends paid | DKK 0 | DKK 0 |
| Proceeds from borrowings | DKK 285.8M | DKK 158.7M |
| Repayments of borrowings | DKK 101.5M | DKK 75.0M |
| Lease liability payments | DKK 15.7M | DKK 14.6M |
| Balance sheet | ||
| Total assets | DKK 5.99B | DKK 5.83B |
| Non-current assets | DKK 5.47B | DKK 5.45B |
| Property, plant & equipment | DKK 549.0M | DKK 456.3M |
| Right-of-use assets | DKK 98.6M | DKK 105.4M |
| Intangible assets & goodwill | DKK 2.10B | DKK 2.10B |
| Current assets | DKK 515.6M | DKK 378.3M |
| Inventories | DKK 229.8M | DKK 132.3M |
| Trade & other receivables | DKK 185.8M | DKK 191.4M |
| Total equity | DKK 2.97B | DKK 2.93B |
| Non-current liabilities | DKK 2.38B | DKK 2.47B |
| Long-term borrowings | DKK 1.63B | DKK 1.71B |
| Lease liabilities (non-current) | DKK 97.8M | DKK 104.4M |
| Current liabilities | DKK 642.3M | DKK 433.0M |
| Current portion of long-term borrowings | DKK 0 | DKK 100.0M |
| Lease liabilities (current) | DKK 11.2M | DKK 10.3M |
| Deferred tax liabilities | DKK 604.3M | DKK 616.8M |
| Derived metrics | ||
| Free cash flow | -DKK 41.6M | DKK 2.4M |
| Operating margin | 20.2% | 29.2% |
| Net margin | 3.1% | 9.6% |
| Return on equity | 1.1% | 3.2% |
| Cash conversion ratio | 2.62× | 2.09× |
| Capex coverage | 0.68× | 1.01× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | DKK 180.0M | DKK 173.7M |
| Cash | DKK 75.5M | DKK 14.2M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | DKK 471.6M | DKK 114.3M |
| Current Prepayments | DKK 5.5M | DKK 3.7M |
| Current Tax Liabilities Current | DKK 44.3M | DKK 36.8M |
| Deferred Tax Assets | DKK 0 | DKK 4.7M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | DKK 138.8M | DKK 149.2M |
| Depreciation Expense | DKK 41.1M | DKK 24.5M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -DKK 608.0K | DKK 189.0K |
| Equity and Liabilities | DKK 5.99B | DKK 5.83B |
| Finance Costs Paid Classified As Operating Activities | DKK 146.5M | DKK 140.3M |
| Finance Income | DKK 3.1M | DKK 9.5M |
| Finance Income Received Classified As Operating Activities | DKK 713.0K | DKK 5.5M |
| Income Tax Relating To Components of Other Comprehensive Income | DKK 1.5M | -DKK 644.0K |
| Income Taxes Paid Refund Classified As Operating Activities | DKK 33.9M | DKK 58.2M |
| Increase Decrease In Cash and Cash Equivalents | DKK 62.0M | -DKK 127.0K |
| Increase Decrease In Working Capital | DKK 131.4M | DKK 72.2M |
| Increase Decrease Through Transactions With Owners | DKK 0 | DKK 0 |
| Increase Decrease Through Transfers and Other Changes Equity | DKK 0 | DKK 0 |
| Intangible Assets Under Development | DKK 164.4M | DKK 112.2M |
| Issued Capital | DKK 400.0K | DKK 400.0K |
| Liabilities | DKK 3.02B | DKK 2.90B |
| Noncurrent Payables To Related Parties | DKK 21.9M | DKK 23.5M |
| Other Comprehensive Income | DKK 6.1M | -DKK 1.2M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | DKK 6.7M | -DKK 2.9M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | DKK 910.0K | DKK 1.1M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | DKK 0 | DKK 0 |
| Other Current Payables | DKK 58.2M | DKK 57.3M |
| Other Current Receivables | DKK 19.0M | DKK 32.1M |
| Other Noncurrent Payables | DKK 16.8M | DKK 16.5M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | DKK 5.3M | DKK 0 |
| Reserve of Cash Flow Hedges | -DKK 6.1M | -DKK 11.3M |
| Reserve of Exchange Differences On Translation | DKK 5.2M | DKK 4.3M |
| Retained Earnings | DKK 2.97B | DKK 2.94B |
| Trade and Other Current Payables To Trade Suppliers | DKK 57.0M | DKK 114.3M |
Every line item above is a fact tagged in FERROSAN MEDICAL DEVICES A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (DKK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.